President & CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Newly DiagnosedManaging DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsJoslin Clinical ResearchInfo for Healthcare ProfessionalsJoslin Clinical Guidelines
Make an AppointmentmyJoslin | Patient PortalAdult ClinicYoung Adult Transition CarePediatricsEye CareWeight Management ProgramsDO ITMental Health & CounselingReferring PhysiciansBillingAfrican American ProgramsAsian ClinicLatino Diabetes InitiativeAbout Joslin ResearchVolunteer for Clinical Research StudiesInfo for Healthcare ProfessionalsClinical Guidelines
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCause MarketingHealthcare ProfessionalsCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Joslin Study Looks for Links between Insulin Resistance and Alzheimer's

Joslin’s Gail Musen, Ph.D., is studying whether sophisticated brain imaging tools can detect early warning signs of Alzheimer’s disease among people with insulin resistance.

Wednesday, August 25, 2010

Joslin’s Gail Musen, Ph.D., is studying whether sophisticated brain imaging tools can detect early warning signs of Alzheimer’s disease among people with insulin resistance.

Using today’s sophisticated brain imaging tools, scientists can search for ways to detect warning signs for Alzheimer’s disease.  Gail Musen, Ph.D., is now studying whether such signs can be detected among people with insulin resistance, who are at higher risk for developing the grim neurodegenerative disease.

Dr. Musen, an assistant investigator in Joslin’s Clinical, Behavioral and Outcomes Research Section, recently received a four-year grant initially valued at $1.6 million from the National Institute of Aging for her investigation.

She explains that people developing Alzheimer’s may show unusual patterns in the brain’s “default network”, a set of areas of the brain that spring into higher gear when the brain is relatively quiet. Importantly, these brain changes can be detected when cognition is still entirely normal. Researchers can analyze this process with functional magnetic resonance imaging (fMRI), which offers a way to measure brain activity by detecting the level of oxygenated blood in brain regions.

Musen and her colleagues will employ fMRI to examine people with various levels of insulin resistance, ranging from those with no insulin resistance to those with type 2 diabetes, both while they are mentally “at rest” and when performing memory tasks.

Additionally, the researchers will examine related changes in brain structure among people with impaired glucose tolerance and diabetes and they will confirm that cognitive function is still completely intact. (This is important to be sure that they are detecting changes before the onset of dementia.)

“This study offers us a really exciting chance over the long run,” says Musen.  “It will help us begin to identify how insulin resistance increases risk for Alzheimer’s, and to identify people who are at risk so that we can try early interventions to decrease that risk.”

Page last updated: November 26, 2014